Breaking News

Upperton Pharma Gains MHRA Approval at Nottingham Facility

The facility gives the green light to support clients from formulation development to late-phase clinical manufacture and product registration.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Upperton Pharma Solutions, a contract development and manufacturing organization (CDMO), has completed a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 square foot development and GMP manufacturing facility in Nottingham, UK. This milestone inspection, conducted by the UK Government’s regulatory authority, marks a significant achievement for Upperton Pharma Solutions following the completion of the build, commissioning, validation and a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters